Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
Stop the silent misdiagnosis: patients' preferences matter.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Oligodendrogenesis in the normal and pathological central nervous system.
From the fundamentals of multiple sclerosis to clinical management.
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
Evolution of tumefactive lesions in multiple sclerosis: A 12-year study with serial imaging in a single patient.
Acute transverse myelitis in childhood: A single centre experience from North India.
Variability in the Cross-Sectional Area and Narrowing of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases.
Biomarkers for MS: Unpuzzling the progressive multiple sclerosis puzzle.
Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Detection of aquaporin-4 antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Special considerations when coding for patients with multiple sclerosis.
Molecular approach to targeted therapy for multiple sclerosis.
Pages
« first
‹ previous
…
515
516
517
518
519
520
521
522
523
…
next ›
last »